You cannot apply for this job anymore (deadline was 15 Mar 2024).
Browse the current job offers or choose an item in the top navigation above.
CAR T-cell therapy for myeloma is ineffective, since all patients eventually relapse. We developed a technology that boosts tumor cell killing by CAR T-cells. The candidate will advance this technology and make it suitable for clinical application.
Job description
This is a research position for a (medical) biologist who is highly motivated, skilled in team work, but also able to work independently, work flexible, brings in own ideas, and pushes the project successfully forward. The candidate is expected to have experience with B cell malignancies and/or CAR T cell design. This is a research position and you deal with patient material, artificial 3D culture models and animal models.
You have a M.Sc. degree in biomedical or biomolecular sciences.
You have hands-on experience in at least two of the following topics; cell engineering, immune cell assays, 3D hydrogel culture, and/or flow cytometry.
You are a team player and can connect well with an interdisciplinary team.
Professional proficiency in Dutch and English (written and spoken) is a requirement.
Conditions of employment
The maximum salary for this position (36 - 36 hours) is € 3.677,00 gross per month based on full-time employment.
In addition, we offer an annual benefit of 8.3%, holiday allowance, travel expenses and career opportunities. The terms of employment are in accordance with the Cao University Medical Centers (UMC).
Department
The work will be located at the laboratory of Victor Peperzak at the Center for Translational Immunology at the UMC Utrecht. Our group focusses on targeting malignant B cells and improvement of cellular immunotherapy, read more. We offer an international environment, highly innovative and motivated team with strong national and international collaborations.